FIELD: pharmaceuticals.
SUBSTANCE: invention provides a compound or a pharmaceutically acceptable salt or solvate thereof selected from the group consisting of the following:
Also the following is provided: pharmaceutical compositions and kits containing a compound of formula I
or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as follows: specified in the claims, and the degree of deuterium enrichment of any one or more of R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 is about 15% or more.
EFFECT: compounds of the invention are useful in treating or slowing the progression of a lysosomal storage disease or neurodegenerative disease in a subject, providing neuroprotection in a subject having a lysosomal disease.
27 cl, 6 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
8-HYDROXYQUINOLINE DERIVATIVES | 2003 |
|
RU2348618C2 |
PYRAZOLINE DIONE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2010 |
|
RU2569855C2 |
METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN | 2014 |
|
RU2669800C2 |
(AZA)INDOLE-, BENZOTHIOPHENE- AND BENZOFURAN-3-SULPHONAMIDES | 2017 |
|
RU2767904C2 |
LEUCINE, ACETYLLECINE AND RELATED ANALOGUES FOR TREATMENT OF DISEASE | 2020 |
|
RU2815373C2 |
USE OF THE COMPOUND OF FORMULA I, A PHARMACEUTICAL COMPOSITION, A MEDICINAL AGENT | 2016 |
|
RU2730854C2 |
THERAPEUTIC AGENTS AGAINST NEURODEGENERATIVE DISEASES | 2017 |
|
RU2756519C2 |
NOVEL ARYLALKYLINDOLES SHOWING AFFINITY TO SEROTONIN RECEPTOR AND USEFUL AS DRUGS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2003 |
|
RU2320663C2 |
NOVEL TETRACYCLIC ARYLSULFONYL-INDOLES WITH AFFINITY FOR SEROTONIN RECEPTORS, ACCETABLE AS MEDICATIONS, METHOD OF THEIR OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2003 |
|
RU2340619C2 |
PYRIDINIL- AND PYRAZINYL(AZA)INDOLSULFONAMIDES | 2019 |
|
RU2799321C2 |
Authors
Dates
2023-12-28—Published
2019-12-06—Filed